LY03021

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY03021, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects [Phase 1]

See pricing